Results 91 to 100 of about 549,379 (280)

Pretreatment SUVmax value to predict outcome in patients with stage III NSCLC receiving concurrent chemoradiotherapy

İstanbul Kuzey Klinikleri, 2019
INTRODUCTION[|]Stage III disease accounts for approximately one-fourth of all non-metastatic non-small cell lung cancer (NSCLC). The patients who are not candidates for curative resection are offered concomitant chemoradiotherapy. In this subgroup, which
Gokhan Yaprak, Melike Özçelik, Cengiz Gemici, Ozgur Seseogullari   +3 more
doaj   +1 more source

Sinonasal Intestinal‐Type Adenocarcinoma in the Netherlands: A Nationwide Study (2008–2022)

Head &Neck, EarlyView.
ABSTRACT Background Intestinal‐type adenocarcinoma (ITAC) is a rare sinonasal malignancy with poor survival. By creating a clinical and epidemiological overview of the Dutch ITAC population between 2008 and 2022, this study aims to identify areas for improvement in ITAC management. Methods A systematic query within the Netherlands Cancer Registry (NCR)
Lise J. van de Velde, Gerben E. Breimer, W. F. Julius Scheurleer, Mischa de Ridder, Lot A. Devriese, Weibel W. Braunius, Remco de Bree, Boukje A. C. van Dijk, Johannes A. Rijken   +8 more
wiley   +1 more source

A phase II single-arm study of induction chemotherapy with cisplatin and gemcitabine followed by concurrent cisplatin and gemcitabine with thoracic radiation for unresectable locally advanced non-small cell lung cancer

Therapeutic Advances in Medical Oncology, 2013
Objectives: The aim of this study was to evaluate the efficacy and tolerability of the combination of cisplatin–gemcitabine with concurrent thoracic radiotherapy for locally advanced non-small cell lung cancer (LA-NSCLC).
Peter Driesen, Marc Lambrechts, Kees Kraaij, Victoria Soldatenkova, Nadia Chouaki, Benoit Colinet   +5 more
doaj   +1 more source

Nutritional status of patients undergoing concurrent chemoradiotherapy for malignant tumor and its influencing factors [PDF]

精准医学杂志
Objective To investigate the nutritional status of patients undergoing concurrent chemoradiotherapy for malignant tumor and its influencing factors.
WANG Peng, WANG Zheng, ZHANG Lichuan, WANG Yujie, LU Qian
doaj   +1 more source

First Case of Lateral Oropharyngectomy Performed Using the Vitom Eagle: A Novel Exoscopic System for Transoral Surgery

Head &Neck, EarlyView.
ABSTRACT Background The Vitom Eagle is a novel exoscopic system, specifically designed for transoral surgery (e.g., lateral oropharyngectomy). No prior study has compared it to existing surgical systems. Methods This case report examines a patient affected by HPV‐related oropharyngeal squamous cell carcinoma treated with transoral lateral ...
Filippo Marchi, Marta Filauro, Elisa Bellini, Andrea Iandelli, Giorgio Peretti   +4 more
wiley   +1 more source

Retrospective cohort study for thrombocytopenia during concurrent chemoradiotherapy for rectal cancer

Frontiers in Oncology
BackgroundThe aim of this article was to establish the clinical prognostic models and identify the predictive radiation dosimetric parameters for thrombocytopenia during concurrent chemoradiotherapy for rectal cancer.MethodsIn this retrospective cohort ...
Yue Teng, Dapeng Ma, Yan Yan, Jianhao Geng, Zhiyan Liu, Xianggao Zhu, Shuai Li, Yangzi Zhang, Hongzhi Wang, Yong Cai, Haizhen Yue, Yongheng Li, Weihu Wang   +12 more
doaj   +1 more source

Deep Learning Pipeline for Automated Assessment of Distances Between Tonsillar Tumors and the Internal Carotid Artery

Head &Neck, EarlyView.
ABSTRACT Background Evaluating the minimum distance (dTICA) between the internal carotid artery (ICA) and tonsillar tumors (TT) on imaging is essential for preoperative planning; we propose a tool to automatically extract dTICA. Methods CT scans of 96 patients with TT were selected from the cancer imaging archive.
Aseem Jain, Ameen Amanian, Nimesh Nagururu, Francis X. Creighton, Eitan Prisman   +4 more
wiley   +1 more source

Emerging treatment options for nasopharyngeal carcinoma

Drug Design, Development and Therapy, 2013
Lu Zhang,1,2 Qiu-Yan Chen,1,2 Huai Liu,1,2 Lin-Quan Tang,1,2 Hai-Qiang Mai1,21State Key Laboratory of Oncology in South China, 2Department of Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Center, Guangzhou, People's Republic of ...
Zhang L, Chen QY, Liu H, Tang LQ, Mai HQ
doaj  

Treatment of Childhood Nasopharyngeal Carcinoma With Induction Chemotherapy and Concurrent Chemoradiotherapy: Results of the Children's Oncology Group ARAR0331 Study.

Journal of Clinical Oncology, 2019
PURPOSE The treatment of childhood nasopharyngeal carcinoma has been adapted from adult regimens; pediatric-specific studies are limited. The ARAR0331 study sought to evaluate the impact of induction chemotherapy (IC) and concurrent chemoradiotherapy ...
C. Rodríguez-Galindo, M. Krailo, M. Krasin, Li Huang, M. B. McCarville, J. Hicks, F. Pashankar, A. Pappo   +7 more
semanticscholar   +1 more source

First‐Line Therapy in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: A Retrospective, Multicenter, Real‐World Study

Head &Neck, EarlyView.
ABSTRACT Background In Europe, pembrolizumab with or without chemotherapy is the recommended first‐line treatment for recurrent or metastatic head and neck squamous cell carcinoma (R/M HNSCC), with a combined positive score (CPS) ≥ 1. In France, the TPExtreme (TPEx) regimen is preferred for CPS < 1.
Alizée Simon, Cyril Abdeddaim, DucTrung Nguyen, Patrice Gallet, Didier Peiffert, Aurélien Lambert, Lionnel Geoffrois   +6 more
wiley   +1 more source